Phase 2Enrolling by invitationHealthspan endpoint

Efficacy of Intravenous Oxytocin to Speed Recovery After THA

Efficacy of Intravenous Oxytocin to Speed Recovery After Total Hip Arthroplasty

Sponsor
Wake Forest University Health Sciences (Academic or other)
Enrollment
80 planned
Conditions
Total Hip Arthroplasty
Interventions
intravenous administration of oxytocin; Placebo
Ages
adults, older adults
Registry
NCT07430228

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to test whether perioperative intravenous (IV) oxytocin compared to placebo results in faster recovery in disability as measured by daily steps over 56 days after Total Hip Arthroplasty (THA).

Primary outcomes

  • Modeled daily steps trajectory

History

  1. Primary completion expected

  2. Expected to start

  3. Last registry update

  4. Registered